Neonatal hyperinsulinism

by Benjamin Glaser, Heddy Landau, M. Alan Permutt
Trends in Endocrinology and Metabolism ()
Get full text at journal

Abstract

Hypoglycemia as a result of hyperinsulinism in the newborn (HI) is a clinically heterogeneous entity that presents a diagnostic and therapeutic challenge to the treating physician. Recent discoveries have shown that mutations in four different ??-cell genes cause HI. However, for many HI patients, the molecular etiology is unknown, and other genes might be involved. The study of the molecular biology of HI has led to a better understanding of pancreatic ??-cell physiology. In the future, this might result in the development of novel drugs for the treatment of both hyperinsulinism and non-insulin-dependent diabetes.

Cite this document (BETA)

Readership Statistics

10 Readers on Mendeley
by Discipline
 
60% Medicine
 
20% Biological Sciences
by Academic Status
 
20% Student (Postgraduate)
 
20% Assistant Professor
 
10% Associate Professor
by Country
 
20% United States
 
10% Mexico

Sign up today - FREE

Mendeley saves you time finding and organizing research. Learn more

  • All your research in one place
  • Add and import papers easily
  • Access it anywhere, anytime

Start using Mendeley in seconds!

Sign up & Download

Already have an account? Sign in